Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis

PloS One
Chih-Hao ChenH C Lee

Abstract

Although genome-wide expression analysis has become a routine tool for gaining insight into molecular mechanisms, extraction of information remains a major challenge. It has been unclear why standard statistical methods, such as the t-test and ANOVA, often lead to low levels of reproducibility, how likely applying fold-change cutoffs to enhance reproducibility is to miss key signals, and how adversely using such methods has affected data interpretations. We broadly examined expression data to investigate the reproducibility problem and discovered that molecular heterogeneity, a biological property of genetically different samples, has been improperly handled by the statistical methods. Here we give a mathematical description of the discovery and report the development of a statistical method, named HTA, for better handling molecular heterogeneity. We broadly demonstrate the improved sensitivity and specificity of HTA over the conventional methods and show that using fold-change cutoffs has lost much information. We illustrate the especial usefulness of HTA for heterogeneous diseases, by applying it to existing data sets of schizophrenia, bipolar disorder and Parkinson's disease, and show it can abundantly and reproducibly uncov...Continue Reading

References

Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y HakakA A Fienberg
Sep 14, 2002·Science·Miguel Ramalho-SantosDouglas A Melton
Sep 14, 2002·Science·Natalia B IvanovaIhor R Lemischka
Sep 23, 2003·Nucleic Acids Research·Paul K TanMargaret C Cam
May 4, 2004·Nature Biotechnology·George L Gabor Miklos, Ryszard Maleszka
Aug 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Renee M MillerHoward J Federoff
Aug 31, 2004·Journal of Neuroscience Research·Christopher AstonBoris P Sokolov
May 21, 2005·Nature Reviews. Drug Discovery·Simon Frantz
Sep 7, 2005·Neurobiology of Disease·Renee M MillerHoward J Federoff
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Jul 1, 2008·Nature Methods·Jay Shendure
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nicole M LewandowskiScott A Small
Oct 29, 2010·Molecular Endocrinology·Sakiko KobayashiDonald P McDonnell
Feb 5, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Fabio Blandini
Aug 16, 2013·BMC Psychiatry·Fayaz SeifuddinPeter P Zandi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Affymetrix
limma
ANOVA
PDGene
HTA
GSEA
SAM
SZGene
BMORR

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Liat Ein-DorEytan Domany
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Katleen De PreterJo Vandesompele
© 2021 Meta ULC. All rights reserved